Lexicon Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 4 published signal records.
Lexicon Pharmaceuticals last closed at $1.68 (-4.55%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -12.6×. Its overall grade ranks 463 of 738 stocks in Healthcare.
About this company
Lexicon Pharmaceuticals last closed at $1.68 (-4.55%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 463/738
Valuation grade B+
Related stocks
- Novo NordiskCustomer
비만·당뇨 치료제 시장의 핵심 고객이자 경쟁 구도에서 주요 파트너/수요처
- Eli LillyCompetitor
비만·당뇨 치료제 분야의 최대 경쟁사 중 하나
- AbbVieCompetitor
대형 제약사로 대사질환·면역질환 포트폴리오에서 경쟁
About Lexicon Pharmaceuticals
- What technical signals does Lexicon Pharmaceuticals (LXRX) have?
- Lexicon Pharmaceuticals current technical signals: no active technical signal.
- Is Lexicon Pharmaceuticals a cup-and-handle pattern?
- No. Lexicon Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Lexicon Pharmaceuticals?
- Market cap: $610.51M. Trailing 12 months PER: -12.6×. Latest quarter PBR: 4.41×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Lexicon Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.